SCHEMBL6364402

SCHEMBL6364402

Cn1nc(-c2c(F)cc(Cl)c(OC(F)F)c2N)c(Cl)c1OC(F)F

nearest known ligand 0.34

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
SCN9A Q15858 1/20 0.34
SLC34A1 Q06495 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6364721 0.93 SCN9A (0.31) SCN9A
SCHEMBL6369901 0.87
SCHEMBL6419145 0.80 SCN9A (0.34) SCN9A
SCHEMBL6364824 0.79 RIPK2 (0.31)
SCHEMBL7683489 0.78 SCN9A (0.33) SCN9ASLC34A1
SCHEMBL6289042 0.78 SCN9A (0.35) SCN9A
SCHEMBL6586722 0.78 SMN1; SMN2 (0.34)
SCHEMBL6364913 0.77 GRIN2D (0.35)
SCHEMBL6364820 0.76 SLC34A1 (0.31) SLC34A1
SCHEMBL6364819 0.76 FPR2 (0.34) SLC34A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050245399-A1 Pyrazole derivatives as herbicidal compositions containing them ISHIHARA SANGYO KAISHA, LTD. 2005-11-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050245399-A1 Pyrazole derivatives as herbicidal compositions containing them DDT, CBR3, CYP4X1 SCN9A 2279/4885SLC34A1 764/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.